Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

89 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Safety and efficacy of sofosbuvir/ledipasvir and sofosbuvir/daclatasvir in the treatment of hepatitis C in patients with decompensated cirrhosis.
El Kassas M, Abdeen N, Omran D, Alboraie M, Salaheldin M, Eltabbakh M, Farghaly R, Emadeldeen M, Afify S, Sweedy A, Ghalwash A, Abbass A, Ezzat S, Tahoon M, ELshazly HM, Hamdy H, Omar H. El Kassas M, et al. Among authors: afify s. Eur J Gastroenterol Hepatol. 2021 Dec 1;33(1S Suppl 1):e877-e882. doi: 10.1097/MEG.0000000000002287. Eur J Gastroenterol Hepatol. 2021. PMID: 34560693
An account of the real-life hepatitis C management in a single specialized viral hepatitis treatment centre in Egypt: results of treating 7042 patients with 7 different direct acting antiviral regimens.
El Kassas M, Alboraie M, Omran D, Salaheldin M, Wifi MN, ElBadry M, El Tahan A, Ezzat S, Moaz E, Farid AM, Omar H, Abouelkhair M, Afify S, Elsaeed K, Shazly Y, Doss W, Esmat G. El Kassas M, et al. Among authors: afify s. Expert Rev Gastroenterol Hepatol. 2018 Dec;12(12):1265-1272. doi: 10.1080/17474124.2018.1476137. Epub 2018 May 24. Expert Rev Gastroenterol Hepatol. 2018. PMID: 29757684
High success rates for the use of ombitasvir/paritaprevir/ritonavir containing regimens in treatment of naïve and experienced chronic hepatitis C genotype 4: Real world results.
El Kassas M, Alboraie M, Omar H, El Latif YA, Algaber MA, El Tahan A, El Halwagy H, Afify S, Elserafy M, Elsaeed K, Doss W. El Kassas M, et al. Among authors: afify s. J Med Virol. 2022 Feb;94(2):667-674. doi: 10.1002/jmv.25478. Epub 2019 Apr 15. J Med Virol. 2022. PMID: 30950069
Egyptian liver library: An indexed database for liver disease evidence in Egypt.
Alboraie M, Youssef N, Sherief AF, Afify S, Wifi MN, Omran D, Hafez E, Omar H, Eltabbakh M, Abdellah M, El Badry M, Salaheldin M, Ahmed Y, Ali-Eldin Z, Farid A, Abdeen N, El Halwagy H, Abdalgaber M, Moaz I, Ezzat S, El Kassas M. Alboraie M, et al. Among authors: afify s. Arab J Gastroenterol. 2019 Jun;20(2):109-113. doi: 10.1016/j.ajg.2019.05.004. Epub 2019 Jun 4. Arab J Gastroenterol. 2019. PMID: 31175077
Liver transplantation in the era of COVID-19.
El Kassas M, Alboraie M, Al Balakosy A, Abdeen N, Afify S, Abdalgaber M, Sherief AF, Madkour A, Abdellah Ahmed M, Eltabbakh M, Salaheldin M, Wifi MN. El Kassas M, et al. Among authors: afify s. Arab J Gastroenterol. 2020 Jun;21(2):69-75. doi: 10.1016/j.ajg.2020.04.019. Epub 2020 May 12. Arab J Gastroenterol. 2020. PMID: 32439237 Free PMC article. Review.
Predictors of severity and development of critical illness of Egyptian COVID-19 patients: A multicenter study.
Omran D, Al Soda M, Bahbah E, Esmat G, Shousha H, Elgebaly A, Abdel Ghaffar M, Alsheikh M, El Sayed E, Afify S, Abdel Hafez S, Elkelany K, Eltayar A, Ali O, Kamal L, Heiba A. Omran D, et al. Among authors: afify s. PLoS One. 2021 Sep 23;16(9):e0256203. doi: 10.1371/journal.pone.0256203. eCollection 2021. PLoS One. 2021. PMID: 34555027 Free PMC article.
89 results